Clinical Education Center

Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Authors: Onwuemene OA, Zantek ND, Rollins-Raval MA, Raval JS, Kiss JE, Ipe TS, Kuchibhatla M, Pagano MB, Wong ECC
J Clin Apher 2019 May 22. doi: 10.1002/jca.21709. [Epub ahead of print]

Specialties: Hematology/Hemostasis/Thrombosis, Oncology

Multiple immune suppressive mechanisms in fibrolamellar carcinoma.

Authors: Kim AK, Gani F, Layman AJ, Besharati S, Zhu Q, Succaria F, Engle EL, Bhaijee F, Goggins MB, Llosa NJ, Pawlik TM, Yarchoan M, Jaffee EM, Simons HC, Taube JM, Anders R.
Cancer Immunol Res. 2019 Mar;doi: 10.1158/2326-6066.CIR-18-0499. [Epub ahead of print]

Specialties: Dermatology, Gastroenterology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.

Rare presentation of renal cell cancer as dysphagia: a case report.

Authors: Padda MS, Si WM.
J Med Case Rep. 2019 Mar;13(1):89. doi: 10.1186/s13256-018-1967-6.

Specialties: Gastroenterology, Oncology, Pathology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.

Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.

Authors: Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, Agarwal-Hashmi R, Aznar CP, Butte MJ, Cowan MJ, Dorsey MJ, Dvorak CC, Kapoor N, Kohn DB, Markert ML, Moore TB, Naides SJ, Sciortino S, Feuchtbaum L, Koupaei RA, Puck JM.
Pediatrics. 2019 Jan 25: doi: 10.1542/peds.2018-2300. [Epub ahead of print]

Specialties: Infectious Disease, Oncology, Pediatrics

Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia.

Authors: Saini NY, Cerny J, Furtado VF, Desmond A, Zhou Z, Raffel G, Puthawala I, Bednarik J, Shanahan L, Miron PM, Woda B, Ramanathan M, Nath R.
Am J Hematol. 2019 Feb;94:209-215.

Specialties: Geriatrics/Age Management, Oncology

Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.

Authors: Chun K, Wenger GD, Chaubey A, Dash DP, Kanagal-Shamanna R, Kantarci S, Kolhe R, Van Dyke DL, Wang L, Wolff DJ, Miron PM.
Cancer Genet. 2018 Dec;228-229:236-250.

Specialties: Genetics, Oncology

PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.

Authors: Assi R, Mahfouz R, Owen R, Gunthorpe M, Chehab FF, Bazarbachi A.
Bone Marrow Transplant. 2018 Dec 10. doi: 10.1038/s41409-018-0419-7. [Epub ahead of print]

Specialties: Genetics, Oncology

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.

Authors: Li Y, Devlin JJ.
Value Health. 2018 Jul;21(7):893-894. Epub 2018 Apr 5.

Specialties: Genetics, Oncology, Women's Health/OB/GYN

Updates on tumours of the salivary glands : 2017 WHO classification [Article in German]

Authors: Ihrler S, Guntinas-Lichius O, Haas C, Mollenhauer M.
Pathologe. 2018;39(1):11-17. doi: 10.1007/s00292-017-0407-5. [Epub ahead of print]

Specialties: Dermatology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Revised prevalence estimate of possible Hereditary Xerocytosis as derived from a large U.S. Laboratory database.

Authors: Kaufman HW, Niles JK, Gallagher DR, Rivera A, Alper SL, Brugnara C, Snyder LM.
Am J Hematol. 2018;93(1):E9-E12

Specialties: Oncology

Read the Key Summary (Download PDF)